Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Abraxane
Abraxane
Bristol Myers Squibb is nixing BeiGene's Abraxane deal in China amid manufacturing woes. Is their cancer rivalry really to blame?
Fierce Pharma
Thu, 10/14/21 - 11:09 am
cancer
Bristol Myers Squibbe
BeiGene
Abraxane
China
drug manufacturing
Roche to withdraw US accelerated approval for Tecentriq to treat breast cancer
Pharmaceutical Business Review
Mon, 08/30/21 - 10:42 am
Roche
Tecentriq
Abraxane
triple negative breast cancer
FDA
accelerated approval
FDA panel questions Roche’s Tecentriq-Abraxane combo in breast cancer, but votes to keep approval in place for now
Fierce Pharma
Tue, 04/27/21 - 11:37 pm
Roche
Tecentriq
Abraxane
breast cancer
FDA
accelerated approvals
Roche's Checkpoint Inhibitor Hits the Mark in Early Triple-Negative Breast Cancer Study
BioSpace
Thu, 06/18/20 - 08:38 pm
Roche
Genentech
Tecentriq
triple negative breast cancer
clinical trials
Celgene
Abraxane
EMA follows FDA to approve Roche's Tecentriq combo for frontline use in triple negative breast cancer
Endpoints
Thu, 08/29/19 - 12:26 pm
Roche
Tecentriq
FDA
Europe
Celgene
Abraxane
triple negative breast cancer
UK gets early access to Roche’s breast cancer immunotherapy
Pharmaforum
Sat, 03/16/19 - 12:18 pm
Roche
Tecentriq
Celgene
Abraxane
UK
triple-negative breast cancer
Celgene’s Abraxane Fails to Hit the Mark in a Phase III Pancreatic Cancer Study
BioSpace
Wed, 03/13/19 - 12:17 pm
Celgene
Abraxane
clinical trials
pancreatic cancer
Roche’s Tecentriq gets fast review in triple negative breast cancer
Pharmaforum
Tue, 11/13/18 - 09:51 am
Roche
Genentech
Tecentriq
Celgene
Abraxane
FDA
triple negative breast cancer
Roche vaults into lead in frontline triple negative breast cancer as Tecentriq/Abraxane combo aces progression-free survival
Endpoints
Mon, 07/2/18 - 09:37 am
Roche
Tecentriq
Genentech
triple negative breast cancer
Celgene
Abraxane
OncoMed's pancreatic cancer drug fails mid-stage study
Yahoo/Reuters
Mon, 04/10/17 - 11:00 am
OncoMed
pancreatic cancer
clinical trials
Celgene
Abraxane
demcizumab
5 Reasons Celgene Will Be a Top Biotech Stock for the Next Decade
Motley Fool
Thu, 03/9/17 - 09:54 am
Celgene
Revlimid
Pomalyst
Abraxane
Otezla
Halozyme Cancer Drug Does Well in Phase 2
Investopedia
Fri, 01/6/17 - 10:13 am
Halozyme
pancreatic cancer
clinical trials
PEGPH20
Eli Lilly
Celgene
gemcitabine
Abraxane
3 Biggest Risks for Celgene Corporation
Motley Fool
Thu, 12/15/16 - 06:44 pm
Celgene
Darzalex
Multiple Myeloma
Allergan
generics
Abraxane
Revlimid
Dinner and a biotech chat: Billionaire Patrick Soon-Shiong talks ‘innovation’ with President-elect Trump
Endpoints
Mon, 11/21/16 - 11:24 am
Donald Trump
Patrick Soon-Shiong
biotech
Abraxane
Celgene
OncoGenex's drug misses the mark in pancreatic cancer
Fierce Biotech
Wed, 09/23/15 - 09:58 am
OncoGenex
pancreatic cancer
apatorsen
Celgene
Abraxane
Could This Tiny Company Threaten Celgene?
Investopedia
Fri, 06/12/15 - 10:47 pm
Celgene
Sorrento Therapeutics
Abraxane
When Will Celgene's Key Patents Expire?
Investopedia
Thu, 04/2/15 - 10:02 am
patents
Celgene
Revlimid
Abraxane
Pomolyst
OncoMed initiates Phase 2 ALPINE trial of tarextumab
Yahoo/Fly on the Wall
Wed, 07/16/14 - 10:38 am
OncoMed
tarextumab
pancreatic cancer
Abraxane
Post-Hoc Analysis of Overall Survival in Phase III MPACT Study of Patients with Advanced Pancreatic Cancer Presented at ASCO 2014
Yahoo/BusinessWire
Sun, 06/1/14 - 11:35 am
pancreatic cancer
Abraxane
gemcitabine
Celgene
Three Companies That Want to Cure Pancreatic Cancer
Yahoo/247WallStreet
Thu, 05/22/14 - 10:10 am
pancreatic cancer
Celgene
Abraxane
Incyte
ruxolitinib
Merrimack Pharmaceuticals
MM-398
Pages
1
2
3
next ›
last »